Kaempferol tetrasaccharide
Kaempferol tetrasaccharide has been studied in 1 paper since 2022: 1 trial in people. The newest paper, Oct 14, 2022: “Kaempferol tetrasaccharides restore skin atrophy via PDK1 inhibition in human skin cells and tissues: Bench and clinical studies”.
1 paper studies it4 findingsUpdated
“Clinical enhancement in skin appearance was noted in multiple participants”
None of its findings points the other way.
- 1 lab in 1 country
- 4 of 4 findings with company ties
- Human trial1
What did studies of Kaempferol tetrasaccharide find?
4Studies of Kaempferol tetrasaccharide measured 4 outcomes; the most studied are extracellular matrix structure (1 study), skin appearance (1) and collagen fibers (1).
Extracellular matrix structure
upin humans1
1 study
Extracellular matrix structure
upin humans1
Kaempferol tetrasaccharide improves extracellular matrix structure in humans.
“immunohistochemical study revealed improvement in the histological appearance of skin tissue and extracellular matrix”
Human trialskin
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Skin appearance
upin humans1
1 study
Skin appearance
upin humans1
Kaempferol tetrasaccharide improves skin appearance in humans.
“Clinical enhancement in skin appearance was noted in multiple participants”
Human trialskin
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Collagen fibers
upin human cells1
1 study
Collagen fibers
upin human cells1
Kaempferol tetrasaccharide increases collagen fibers in human cells.
“an increase in collagen fiber was observed in the skin cell and human skin equivalent”
Cellsskin
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Cellular senescence
downin human cells1
1 study
Cellular senescence
downin human cells1
Kaempferol tetrasaccharide decreases cellular senescence in human cells.
“Natural phytochemical kaempferol tetrasaccharides resulted in a significant reduction in cellular senescence”
Cellsskin
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie